DICE Therapeutics, Inc. Quarterly Return On Equity in % from Q3 2021 to Q2 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
DICE Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q3 2021 to Q2 2023.
  • DICE Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2023 was -22 %, a 9.31% increase year-over-year.
  • DICE Therapeutics, Inc. annual Return On Equity for 2022 was -24 %, a 37.4% increase from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2023 -22 +2.26 +9.31% Apr 1, 2023 Jun 30, 2023
Q1 2023 -22 +5.41 +19.7% Jan 1, 2023 Mar 31, 2023
Q4 2022 -24 +14.3 +37.4% Oct 1, 2022 Dec 31, 2022
Q3 2022 -26.8 +82.8 +75.5% Jul 1, 2022 Sep 30, 2022
Q2 2022 -24.3 Apr 1, 2022 Jun 30, 2022
Q1 2022 -27.4 Jan 1, 2022 Mar 31, 2022
Q4 2021 -38.3 Oct 1, 2021 Dec 31, 2021
Q3 2021 -110 Jul 1, 2021 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.